Latest Quarter
Q1 FY2026ended 2026-03-31 · filed 2026-05-06
$194.01M
$1.17M
$14.01M
$0.00
$235.71M
$2.02B
$621.99M
$482.42M
What this quarter tells us
For Q1 FY2026, GoodRx reported revenue of $194.0 million, a decrease of 4.4% year-over-year. Net income was $1.2 million, down 89.4% from the prior year. Operating income fell 40.1% to $14.0 million, and diluted EPS was $0.00, a 100% decline. The company held $235.7 million in cash, with total equity of $622.0 million and long-term debt of $482.4 million.
- •Revenue declined 4.4% YoY to $194.0 million.
- •Net income dropped 89.4% to $1.2 million.
- •Operating income fell 40.1% to $14.0 million.
- •Diluted EPS was $0.00, down 100% YoY.
Informational summary based on SEC XBRL figures · generated by deepseek-v4-flash. Not investment advice.